For the last decade, IFI6 was generally regarded as a pro-survival gene since it is expressed at high levels in gastric cancer, colorectal cancer, breast cancer, myeloma, tongue squamous cell carcinoma, and in psoriasis [14, 28–32]. This evidence concerns the gene IFI6 and breast carcinoma.